ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 46.0 | 15.7 | 24.2 |
| Other income | 14.5 | -3.4 | 0.6 |
| Total income | 60.4 | 12.3 | 24.8 |
| Profit before exceptional items & tax | 3.8 | -3.1 | -5.8 |
| Profit before tax | 3.8 | -3.1 | -5.8 |
| Net profit | 2.1 | -3.2 | 0.8 |
| Operating margin | 6.3% | -25.2% | -23.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +162.50% |
|---|---|
| Revenue, year on year | +90.10% |
BSE results filing, BSE: 542803. Figures extracted from the filing.
Vaxfab Enterprises Ltd: key numbers
- Share price
- ₹64.57
- Market cap
- ₹151.9 Cr
- Revenue (annual)
- ₹94.11 Cr
- Net profit (annual)
- ₹3.64 Cr
- P/E (TTM)
- -31.3×Sector 46.8×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 0.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vaxfab Enterprises Ltd
All →Vaxfab Enterprises Board Meeting Date
Vaxfab Enterprises will hold a board meeting on 14 November 2026 to consider unaudited quarterly results. Trading window stays closed until 48 hours after results.
Vaxfab Enterprises Legal & Regulatory
Vaxfab Enterprises appointed ASGM & Co. as forensic auditor for FY2023-FY2025 records. The probe follows management transition gaps and GST notices, with fees of ₹3 lakh.
- Value
- ₹0.03 Cr
Vaxfab Enterprises Other Announcement
Vaxfab Enterprises Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026. The filing provides current stake details.
Vaxfab Enterprises Management Change
Vaxfab Enterprises appointed Mrs. Dhruvi Patel as Company Secretary and Compliance Officer. This follows the resignation of Mrs. Neha Rishabh Bardia from the same position.
Vaxfab Enterprises Annual General Meeting
Vaxfab Enterprises Ltd held its Annual General Meeting on September 29, 2026. Shareholders approved financial statements, director reappointment, auditor appointment, and authorized capital increase.
Vaxfab Enterprises Other Announcement
The company filed the confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.